TY  - JOUR
TI  - Hemagglutination Inhibition (HI) Assay of Influenza Viruses with Monoclonal Antibodies
AU  - Wu, Ying 
AU  - Cho, MyungSam 
AU  - Shore, David 
AU  - Song, Manki 
AU  - Choi, JungAh 
AU  - Jiang, Tao 
AU  - Deng, Yong-Qiang 
AU  - Bourgeois, Melissa 
AU  - Almli, Lynn 
AU  - Yang, Hua 
AU  - Chen, Li-Mei 
AU  - Shi, Yi 
AU  - Qi, Jianxu 
AU  - Li, An 
AU  - Yi, Kye Sook
AU  - Chang, MinSeok 
AU  - Bae, Jin Soo
AU  - Lee, HyunJoo 
AU  - Shin, JiYoung 
AU  - Stevens, James 
AU  - Hong, SeoungSuh 
AU  - Qin, Cheng-Feng 
AU  - Gao, George F.
AU  - Chang, Shin Jae
AU  - Donis, Ruben O.
VL  - 6
IS  - 11
PY  - 2016
DA  - 2016/06/05
SP  - e1828
C1  - Bio-protocol 2016;6:e1828
DO  - 10.21769/BioProtoc.1828
UR  - https://doi.org/10.21769/BioProtoc.1828
AB  - Heamagglutination is inhibited when antibodies are present because antibodies to the influenza virus will prevent attachment of the virus to red blood cells. The highest dilution of antibody that prevents hemagglutination is called the HI titer. Human monoclonal antibodies generated from single human B cells were tested to characterize their ability to inhibit hemagglutination against virus A/California/07/2009 (H1N1) and A/Brisbane/10/2007 (H3N2).
KW  - Haemagglutination inhibition
KW  - Influenza
KW  - Antibody
JF  - Bio-protocol
SN  - 2331-8325
PB  - Bio-protocol LLC.
BIO101  - False